Bartok B, Firestein GS (2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 233(1):233–255

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dinesh P, Rasool M (2018) Berberine inhibits IL-21/IL-21R mediated inflammatory proliferation of fibroblast-like synoviocytes through the attenuation of PI3K/Akt signaling pathway and ameliorates IL-21 mediated osteoclastogenesis. Cytokine 106:54–56

Article  CAS  PubMed  Google Scholar 

Guma M, Sanchez-Lopez E, Lodi A, Garcia-Carbonell R, Tiziani S, Karin M, Lacal JC, Firestein GS (2015) Choline kinase inhibition in rheumatoid arthritis. Ann Rheum Dis 74(7):1399–1407

Article  CAS  PubMed  Google Scholar 

Hao Y, Xie L, Xia J, Liu Z, Yang B, Zhang M (2021) Plasma interleukin-21 levels and genetic variants are associated with susceptibility to rheumatoid arthritis. BMC Musculoskelet Disord 22(1):246

Article  CAS  PubMed  PubMed Central  Google Scholar 

Janardhan S, Srivani P, Sastry GN (2006) Choline kinase: an important target for cancer. Curr Med Chem 13(10):1169–1186

Article  CAS  PubMed  Google Scholar 

Jüngel A, Distler JH, Kurowska-Stolarska M, Seemayer CA, Seibl R, Forster A, Michel BA, Gay RE, Emmrich F, Gay S, Distler O (2004) Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheumatol 50(5):1468–1476

Article  Google Scholar 

Katz-Brull R, Degani H (1996) Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer Res 16(3B):1375–1380

CAS  PubMed  Google Scholar 

Ko SY (2012) Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells. Arch Oral Biol 57(12):1623–1632

Article  CAS  PubMed  Google Scholar 

Park KS, Chong Y, Kim MK (2016) Myricetin: biological activity related to human health. Appl Biol Chem 59:259–269

Article  CAS  Google Scholar 

Ramírez de Molina A, Gutiérrez R, Ramos MA, Silva JM, Silva J, Bonilla F, Sánchez JJ, Lacal JC (2002a) Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy. Oncogene 21(27):4317–4322

Article  PubMed  Google Scholar 

Ramírez de Molina A, Penalva V, Lucas L, Lacal JC (2002b) Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K. Oncogene 21(6):937–946

Article  PubMed  Google Scholar 

Ramírez de Molina A, Rodríguez-González A, Gutiérrez R, Martínez-Piñeiro L, Sánchez J, Bonilla F, Rosell R, Lacal J (2002c) Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun 296(3):580–583

Article  PubMed  Google Scholar 

Ramírez de Molina A, Sarmentero-Estrada J, Belda-Iniesta C, Tarón M, Ramírez de Molina V, Cejas P, Skrzypski M, Gallego-Ortega D, de Castro J, Casado E, García-Cabezas MA, Sánchez JJ, Nistal M, Rosell R, González-Barón M, Lacal JC (2007) Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study. Lancet Oncol 8(10):889–897

Article  PubMed  Google Scholar 

Rodríguez-González A, Ramírez de Molina A, Bañez-Coronel M, Megias D, Lacal JC (2005) Inhibition of choline kinase renders a highly selective cytotoxic effect in tumour cells through a mitochondrial independent mechanism. Int J Oncol 26(4):999–1008

PubMed  Google Scholar 

Samarpita S, Ganesan R, Rasool M (2020) Cyanidin prevents the hyperproliferative potential of fibroblast-like synoviocytes and disease progression via targeting IL-17A cytokine signalling in rheumatoid arthritis. Toxicol Appl Pharmacol 391:114917

Article  CAS  PubMed  Google Scholar 

Sanchez-Lopez E, Zimmerman T, Gomez del Pulgar T, Moyer MP, LacalSanjuan JC, Cebrian A (2013) Choline kinase inhibition induces exacerbated endoplasmic reticulum stress and triggers apoptosis via CHOP in cancer cells. Cell Death Dis 4(11):e933

Article  CAS  PubMed  PubMed Central  Google Scholar 

Varkey R, Du Q, Karnell JL, Xiao X, Casey KA, Woods R, Rosenthal K, Wilson S, Dall’Acqua WF, Wu H, Herbst R, Ettinger R, Damschroder M (2019) Discovery and characterization of potent IL-21 neutralizing antibodies via a novel alternating antigen immunization and humanization strategy. PloS one 14(1):e0211236

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang P, Li S, Wang X (2016) Myricetin exerts anti-osteoarthritic effects in IL-1β stimulated SW1353 cells via regulating matrix metalloproteinases and modulating JNK/P38MAPK/Ap-1/c-Fos and JAK/STAT signalling. Int J Pharmacol 12:440–450

Article  CAS  Google Scholar 

Xing R, Jin Y, Sun L, Yang L, Li C, Li Z, Liu X, Zhao J (2016) Interleukin-21 induces migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis. Clin Exp Immunol 184(2):147–158

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yalcin A, Clem B, Makoni S, Clem A, Nelson K, Thornburg J, Siow D, Lane AN, Brock SE, Goswami U, Eaton JW, Telang S, Chesney J (2010) Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling. Oncogene 29(1):139–149

Article  CAS  PubMed  Google Scholar 

Young DA, Hegen M, Ma HL, Whitters MJ, Albert LM, Lowe L, Senices M, Wu PW, Sibley B, Leathurby Y, Brown TP, Nickerson-Nutter C, Keith JC Jr, Collins M (2007) Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheumatol 56(4):1152–1163

Article  CAS  Google Scholar 

Yuan X, Liu Y, Hua X, Deng X, Sun P, Yu C, Chen L, Yu S, Liu S, Pang H (2015) Myricetin ameliorates the symptoms of collagen-induced arthritis in mice by inhibiting cathepsin K activity. Immunopharmacol Immunotoxicol 37(6):513–519

Article  CAS  PubMed  Google Scholar